CD4 and prostate cancer: Radiotherapy was reported to cause a global reduction in circulating lymphocyte subsets in patients treated for stage I–II prostate cancer [52] or to induce an increase in CD4+ Treg in the peripheral blood of patients with diverse solid cancers [53].